Why an HIV vaccine trial in South Africa could spell the end of our battle with AIDS

The study, called HVTN 702, is to begin Wednesday and aims to enroll 5,400 sexually active men and women aged between 18 and 35

from IBTimes.co.in : Science http://ift.tt/2fBoSKf